Magnetically responsive polycaprolactone nanocarriers for application in the biomedical field: magnetic hyperthermia, magnetic resonance imaging, and magnetic drug delivery.


Journal

RSC advances
ISSN: 2046-2069
Titre abrégé: RSC Adv
Pays: England
ID NLM: 101581657

Informations de publication

Date de publication:
27 Nov 2020
Historique:
received: 01 09 2020
accepted: 22 11 2020
entrez: 6 5 2022
pubmed: 8 12 2020
medline: 8 12 2020
Statut: epublish

Résumé

There are huge demands on multifunctional nanocarriers to be used in nanomedicine. Herein, we present a simple and efficient method for the preparation of multifunctional magnetically responsive polymeric-based nanocarriers optimized for biomedical applications. The hybrid delivery system is composed of drug-loaded polymer nanoparticles (poly(caprolactone), PCL) coated with a multilayer shell of polyglutamic acid (PGA) and superparamagnetic iron oxide nanoparticles (SPIONs), which are known as bio-acceptable components. The PCL nanocarriers with a model anticancer drug (Paclitaxel, PTX) were formed by the spontaneous emulsification solvent evaporation (SESE) method, while the magnetically responsive multilayer shell was formed

Identifiants

pubmed: 35519668
doi: 10.1039/d0ra07507h
pii: d0ra07507h
pmc: PMC9058288
doi:

Types de publication

Journal Article

Langues

eng

Pagination

43607-43618

Informations de copyright

This journal is © The Royal Society of Chemistry.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

J Control Release. 2019 May 28;302:90-104
pubmed: 30946854
Radiologe. 1996 Feb;36(2):153-63
pubmed: 8867433
Int J Pharm. 2004 Jun 11;277(1-2):19-24
pubmed: 15158965
Adv Drug Deliv Rev. 2008 Aug 17;60(11):1252-1265
pubmed: 18558452
Angew Chem Int Ed Engl. 2008;47(38):7284-8
pubmed: 18696519
Eur J Pharm Sci. 2000 Oct;11 Suppl 2:S81-91
pubmed: 11033430
Radiology. 2003 Dec;229(3):838-46
pubmed: 14657318
Nanomedicine (Lond). 2009 Oct;4(7):799-812
pubmed: 19839815
Transplantation. 2003 Oct 15;76(7):1123-30
pubmed: 14557764
J Mater Sci. 2015;50(2):493-518
pubmed: 26346887
J Colloid Interface Sci. 2016 Mar 15;466:62-71
pubmed: 26707773
Nanoscale. 2014 Jan 7;6(1):65-75
pubmed: 24280870
Biomaterials. 2005 Jun;26(18):3995-4021
pubmed: 15626447
J Biomed Mater Res. 2000 Feb;49(2):167-75
pubmed: 10571902
Angew Chem Int Ed Engl. 2007;46(8):1222-44
pubmed: 17278160
Biomaterials. 2005 Mar;26(7):729-38
pubmed: 15350777
Bioconjug Chem. 2011 Oct 19;22(10):1879-903
pubmed: 21830812
Cancer Sci. 2009 Apr;100(4):572-9
pubmed: 19462526
Eur Biophys J. 2006 May;35(5):446-50
pubmed: 16447039
Nanomaterials (Basel). 2020 Mar 10;10(3):
pubmed: 32164194
ACS Nano. 2010 Dec 28;4(12):7151-60
pubmed: 21043459
Langmuir. 2010 Aug 3;26(15):12592-7
pubmed: 20604580
ACS Appl Mater Interfaces. 2019 Mar 20;11(11):10905-10913
pubmed: 30810298
Adv Drug Deliv Rev. 2013 May;65(5):732-43
pubmed: 23123295
Biomaterials. 2015 Aug;60:62-71
pubmed: 25985153
Nat Rev Drug Discov. 2008 Jul;7(7):591-607
pubmed: 18591980
Radiology. 1977 May;123(2):463-74
pubmed: 322205
Nano Lett. 2006 Nov;6(11):2427-30
pubmed: 17090068
Expert Opin Drug Deliv. 2009 Jan;6(1):53-70
pubmed: 19236208
Soft Matter. 2006 Dec 12;2(1):18-23
pubmed: 32646088
Int J Nanomedicine. 2018 Sep 06;13:5159-5172
pubmed: 30233178
Cancer Res. 1996 Oct 15;56(20):4686-93
pubmed: 8840985
Adv Drug Deliv Rev. 2006 Dec 1;58(14):1471-504
pubmed: 17116343
Int J Mol Sci. 2019 Dec 26;21(1):
pubmed: 31888066
Cancer Res. 1986 Dec;46(12 Pt 1):6387-92
pubmed: 2946403
Pharmaceutics. 2019 Nov 12;11(11):
pubmed: 31726769
Adv Colloid Interface Sci. 2015 Aug;222:678-91
pubmed: 25453660
J Nanosci Nanotechnol. 2012 Jun;12(6):5111-6
pubmed: 22905587
Ann Surg. 1957 Oct;146(4):596-606
pubmed: 13470751
Nat Rev Drug Discov. 2014 Nov;13(11):813-27
pubmed: 25287120
ACS Appl Mater Interfaces. 2016 Sep 28;8(38):25043-50
pubmed: 27588711
ACS Nano. 2008 May;2(5):889-96
pubmed: 19206485
Expert Opin Drug Deliv. 2014 Sep;11(9):1449-70
pubmed: 24870351
ACS Appl Mater Interfaces. 2015 Sep 2;7(34):19342-52
pubmed: 26270412
J Am Chem Soc. 2005 Aug 3;127(30):10676-85
pubmed: 16045355
Crit Rev Oncol Hematol. 2002 Apr;42(1):35-56
pubmed: 11923067
Colloids Surf B Biointerfaces. 2015 Nov 1;135:109-115
pubmed: 26241922
Small. 2006 Oct;2(10):1144-7
pubmed: 17193579
Adv Drug Deliv Rev. 2010 Aug 30;62(11):1052-1063
pubmed: 20709124

Auteurs

Marta Szczęch (M)

Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences Krakow Poland ncszczep@cyf-kr.edu.pl +48-124251923 +48-126395121.

Davide Orsi (D)

Department of Mathematical, Physical and Computer Sciences, University of Parma Parma Italy.

Natalia Łopuszyńska (N)

Henryk Niewodniczański Institute of Nuclear Physics, Polish Academy of Sciences Krakow Poland.

Luigi Cristofolini (L)

Department of Mathematical, Physical and Computer Sciences, University of Parma Parma Italy.

Krzysztof Jasiński (K)

Henryk Niewodniczański Institute of Nuclear Physics, Polish Academy of Sciences Krakow Poland.

Władysław P Węglarz (WP)

Henryk Niewodniczański Institute of Nuclear Physics, Polish Academy of Sciences Krakow Poland.

Franca Albertini (F)

Institute of Materials for Electronics and Magnetism, National Research Council (CNR) Parma Italy.

Sami Kereïche (S)

Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University Prague Czech Republic.

Krzysztof Szczepanowicz (K)

Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences Krakow Poland ncszczep@cyf-kr.edu.pl +48-124251923 +48-126395121.

Classifications MeSH